MétaCan
Menu
Back to cohort
Record W3173471877 · doi:10.3390/jcm10132912

Landscape of Preterm Birth Therapeutics and a Path Forward

2021· review· en· W3173471877 on OpenAlexafffund
Brahm Coler, Oksana Shynlova, Adam Boros-Rausch, Stephen J. Lye, Stephen A. McCartney, Kelycia B Leimert, Wendy Xu, Sylvain Chemtob, David M. Olson, Miranda Li, Emily M. Huebner, Anna Curtin, Alisa Kachikis, Leah M. Savitsky, Jonathan Paúl, Roger Smith, Kristina M. Adams Waldorf

Bibliographic record

VenueJournal of Clinical Medicine · 2021
Typereview
Languageen
FieldMedicine
TopicPreterm Birth and Chorioamnionitis
Canadian institutionsUniversité de MontréalUniversity of AlbertaUniversity of Toronto
FundersEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Health and Medical Research CouncilNational Institute of Allergy and Infectious DiseasesMedical Research CouncilCanadian Institutes of Health ResearchUniversity of WashingtonChildren's Health Research InstituteWomen and Children's Health Research InstituteStollery Children’s Hospital FoundationNational Institutes of HealthChildren's Hospital FoundationMarch of Dimes FoundationBurroughs Wellcome Fund
KeywordsMedicineIntensive care medicineTocolytic agentTocolyticAdverse effectDrug developmentDrugPharmacologyFetusPregnancyPreterm labor

Abstract

fetched live from OpenAlex

Preterm birth (PTB) remains the leading cause of infant morbidity and mortality. Despite 50 years of research, therapeutic options are limited and many lack clear efficacy. Tocolytic agents are drugs that briefly delay PTB, typically to allow antenatal corticosteroid administration for accelerating fetal lung maturity or to transfer patients to high-level care facilities. Globally, there is an unmet need for better tocolytic agents, particularly in low- and middle-income countries. Although most tocolytics, such as betamimetics and indomethacin, suppress downstream mediators of the parturition pathway, newer therapeutics are being designed to selectively target inflammatory checkpoints with the goal of providing broader and more effective tocolysis. However, the relatively small market for new PTB therapeutics and formidable regulatory hurdles have led to minimal pharmaceutical interest and a stagnant drug pipeline. In this review, we present the current landscape of PTB therapeutics, assessing the history of drug development, mechanisms of action, adverse effects, and the updated literature on drug efficacy. We also review the regulatory hurdles and other obstacles impairing novel tocolytic development. Ultimately, we present possible steps to expedite drug development and meet the growing need for effective preterm birth therapeutics.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.982
Threshold uncertainty score0.763

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0060.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.135
GPT teacher head0.464
Teacher spread0.328 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designOther design
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations45
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical MedicineSame topicPreterm Birth and ChorioamnionitisFrench-language works237,207